AVITA Medical IncNASDAQ:RCEL
- LAST PRICE13.3400
- TODAY'S CHANGE (%)0.4700 (3.6519%)
- Bid / Lots13.1400/ 1
- Ask / Lots13.9500/ 10
- Open / Previous Close12.8300 / 12.8700
- Day Range
- 52 Week Range
- Volume143,210
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | RCEL |
|---|---|---|
| 09:32 ET | 7370 | 12.9 |
| 09:33 ET | 2394 | 12.95 |
| 09:42 ET | 100 | 13.055 |
| 09:44 ET | 1452 | 13.22 |
| 09:50 ET | 116 | 13.315 |
| 09:51 ET | 1700 | 13.44 |
| 09:53 ET | 900 | 13.44 |
| 09:55 ET | 800 | 13.405 |
| 10:02 ET | 1902 | 13.49 |
| 10:04 ET | 129 | 13.48 |
| 10:06 ET | 1442 | 13.45 |
| 10:08 ET | 100 | 13.52 |
| 10:09 ET | 2113 | 13.49 |
| 10:11 ET | 100 | 13.475 |
| 10:13 ET | 100 | 13.42 |
| 10:18 ET | 300 | 13.42 |
| 10:20 ET | 372 | 13.485 |
| 10:22 ET | 800 | 13.42 |
| 10:26 ET | 300 | 13.41 |
| 10:29 ET | 400 | 13.41 |
| 10:31 ET | 238 | 13.4164 |
| 10:33 ET | 2300 | 13.34 |
| 10:36 ET | 1607 | 13.36 |
| 10:38 ET | 297 | 13.38 |
| 10:40 ET | 100 | 13.39 |
| 10:45 ET | 1200 | 13.41 |
| 10:47 ET | 100 | 13.385 |
| 10:49 ET | 601 | 13.3557 |
| 10:54 ET | 1284 | 13.23 |
| 10:56 ET | 300 | 13.2 |
| 10:58 ET | 400 | 13.27 |
| 11:03 ET | 100 | 13.21 |
| 11:05 ET | 300 | 13.25 |
| 11:09 ET | 1680 | 13.345 |
| 11:12 ET | 100 | 13.29 |
| 11:14 ET | 300 | 13.4 |
| 11:18 ET | 100 | 13.435 |
| 11:30 ET | 100 | 13.44 |
| 11:34 ET | 100 | 13.39 |
| 11:38 ET | 400 | 13.48 |
| 11:39 ET | 334 | 13.5 |
| 11:45 ET | 100 | 13.47 |
| 11:48 ET | 1050 | 13.5 |
| 11:52 ET | 1080 | 13.52 |
| 11:56 ET | 200 | 13.59 |
| 11:57 ET | 3174 | 13.64 |
| 11:59 ET | 100 | 13.59 |
| 12:06 ET | 200 | 13.62 |
| 12:08 ET | 100 | 13.57 |
| 12:14 ET | 300 | 13.61 |
| 12:21 ET | 300 | 13.5763 |
| 12:24 ET | 100 | 13.57 |
| 12:26 ET | 700 | 13.605 |
| 12:32 ET | 400 | 13.57 |
| 12:33 ET | 100 | 13.54 |
| 12:37 ET | 1500 | 13.4971 |
| 12:42 ET | 400 | 13.56 |
| 12:46 ET | 500 | 13.61 |
| 12:48 ET | 810 | 13.56 |
| 12:55 ET | 100 | 13.56 |
| 01:00 ET | 2600 | 13.61 |
| 01:08 ET | 200 | 13.56 |
| 01:09 ET | 400 | 13.56 |
| 01:11 ET | 100 | 13.46 |
| 01:13 ET | 2000 | 13.5502 |
| 01:15 ET | 300 | 13.46 |
| 01:18 ET | 100 | 13.53 |
| 01:20 ET | 100 | 13.46 |
| 01:24 ET | 400 | 13.46 |
| 01:26 ET | 200 | 13.43 |
| 01:31 ET | 100 | 13.43 |
| 01:33 ET | 100 | 13.43 |
| 01:38 ET | 500 | 13.53 |
| 01:42 ET | 100 | 13.5 |
| 01:45 ET | 100 | 13.47 |
| 01:54 ET | 200 | 13.47 |
| 02:00 ET | 200 | 13.39 |
| 02:07 ET | 300 | 13.46 |
| 02:09 ET | 300 | 13.46 |
| 02:12 ET | 300 | 13.51 |
| 02:16 ET | 200 | 13.47 |
| 02:20 ET | 200 | 13.535 |
| 02:27 ET | 100 | 13.535 |
| 02:30 ET | 200 | 13.6 |
| 02:32 ET | 100 | 13.535 |
| 02:34 ET | 800 | 13.54 |
| 02:38 ET | 125 | 13.615 |
| 02:39 ET | 100 | 13.67 |
| 02:41 ET | 100 | 13.56 |
| 02:50 ET | 100 | 13.54 |
| 02:52 ET | 300 | 13.565 |
| 02:56 ET | 100 | 13.53 |
| 02:59 ET | 1498 | 13.53 |
| 03:01 ET | 1400 | 13.5 |
| 03:03 ET | 870 | 13.43 |
| 03:06 ET | 100 | 13.42 |
| 03:08 ET | 300 | 13.44 |
| 03:10 ET | 800 | 13.41 |
| 03:12 ET | 100 | 13.36 |
| 03:15 ET | 410 | 13.35 |
| 03:17 ET | 400 | 13.37 |
| 03:19 ET | 300 | 13.4 |
| 03:24 ET | 201 | 13.3577 |
| 03:28 ET | 2300 | 13.38 |
| 03:30 ET | 600 | 13.38 |
| 03:32 ET | 400 | 13.47 |
| 03:37 ET | 300 | 13.47 |
| 03:39 ET | 2610 | 13.45 |
| 03:42 ET | 100 | 13.49 |
| 03:44 ET | 1498 | 13.44 |
| 03:46 ET | 100 | 13.43 |
| 03:48 ET | 1484 | 13.435 |
| 03:50 ET | 1587 | 13.46 |
| 03:51 ET | 700 | 13.405 |
| 03:53 ET | 1102 | 13.42 |
| 03:55 ET | 1000 | 13.39 |
| 03:57 ET | 531 | 13.35 |
| 04:00 ET | 16336 | 13.34 |
Nov 12, 2024
AVITA Medical Announces Exclusive Distribution Agreement to Expand to Australia and New Zealand, from 4:03PM ET on Tuesday Nov 12, 2024 by Dow Jones
4:03PM ET on Tuesday Nov 12, 2024 by Dow Jones
Nov 8, 2024
DJ Avita Medical Price Target Raised to $12.00/Share From $9.00 by Piper Sandler, from 9:05AM ET on Friday Nov 08, 2024 by Dow Jones
9:05AM ET on Friday Nov 08, 2024 by Dow JonesAVITA Medical to Host Investor Webinar Briefing, from 9:00AM ET on Friday Nov 08, 2024 by Dow Jones
9:00AM ET on Friday Nov 08, 2024 by Dow Jones
Nov 7, 2024
AVITA Medical Reports Third Quarter Financial Results, from 4:03PM ET on Thursday Nov 07, 2024 by Dow Jones
4:03PM ET on Thursday Nov 07, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
AVITA Medical Inc | 337.4M | -6.0x | --- |
Contineum Therapeutics Inc | 369.7M | -10.1x | --- |
Zenas Biopharma Inc | 415.4M | -3.8x | --- |
Codexis Inc | 352.4M | -5.3x | --- |
Tango Therapeutics Inc | 389.9M | -3.4x | --- |
Aclaris Therapeutics Inc | 308.6M | -7.3x | --- |
Company Information
AVITA Medical, Inc. is a commercial-stage regenerative medicine company. The Company is a provider of regenerative medicine addressing unmet medical needs in burn injuries, full-thickness skin defects, and in skin repigmentation, such as vitiligo. Its RECELL platform a single use, stand-alone, battery operated, autologous cell harvesting device containing enzymatic and buffer solutions, sterile surgical instruments, and actuators. RECELL is used for the treatment of thermal burn wounds and full-thickness skin defects, and for repigmentation of stable depigmented vitiligo lesions. The platform technology of the RECELL System enables a thin split-thickness skin sample from the patient to be processed and prepared, producing an autologous cellular suspension called Spray-On Skin Cells. These Spray-On Skin Cells are prepared at the point of care in as little as 30 minutes, providing a new way to treat thermal burn wounds and full-thickness skin defects.
Contact Information
- Headquarters
- 28159 Avenue Stanford, Suite 220VALENCIA, CA, United States 91355
- Phone
- 661-367-9170
- Fax
- ---
Executives
- Independent Non-Executive Chairman of the board
- Lou Panaccio
- President, Chief Executive Officer, Executive Director
- James Corbett
- Chief Financial Officer
- David O'Toole
- Chief Legal and Compliance Officer, Corporate Secretary
- Nicole Kelsey
- Independent Non-Executive Director
- Jeremy Cook
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $337.4M |
|---|---|
Revenue (TTM) | $60.0M |
Shares Outstanding | 26.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.58 |
EPS | $-2.23 |
Book Value | $1.91 |
P/E Ratio | -6.0x |
Price/Sales (TTM) | 5.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -98.12% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
